Tarsus Pharmaceuticals In... (TARS)

TARS trades at $54.57, 36.4% above the near-term max pain of $40 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($22.5-$55), signaling increased put positioning or downside protection. Key magnetic zone at 40 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for TARS shows a downward trend from 55 to 22.5, indicating bearish sentiment or hedging activity. The 82% spread signals divergent expectations across timeframes. Most levels below 54.57 may cap rallies. Strong magnetic level at 40 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.